NO996234L - Sprayformuleringer av antihyperalgesiske opiater og fremgangsmåte for behandling av topiske hyperalgesiske forhold og kløe med disse - Google Patents

Sprayformuleringer av antihyperalgesiske opiater og fremgangsmåte for behandling av topiske hyperalgesiske forhold og kløe med disse

Info

Publication number
NO996234L
NO996234L NO996234A NO996234A NO996234L NO 996234 L NO996234 L NO 996234L NO 996234 A NO996234 A NO 996234A NO 996234 A NO996234 A NO 996234A NO 996234 L NO996234 L NO 996234L
Authority
NO
Norway
Prior art keywords
itching
therewith
methods
spray formulations
treating topical
Prior art date
Application number
NO996234A
Other languages
English (en)
Other versions
NO996234D0 (no
Inventor
John J Farrar
An-Chih Chang
Alan L Maycock
Imre Balogh
Original Assignee
Adolor Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adolor Corp filed Critical Adolor Corp
Publication of NO996234D0 publication Critical patent/NO996234D0/no
Publication of NO996234L publication Critical patent/NO996234L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
NO996234A 1997-07-14 1999-12-16 Sprayformuleringer av antihyperalgesiske opiater og fremgangsmåte for behandling av topiske hyperalgesiske forhold og kløe med disse NO996234L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/892,389 US5798093A (en) 1997-03-14 1997-07-14 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith
PCT/US1998/012832 WO1999003457A1 (en) 1997-07-14 1998-06-19 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith

Publications (2)

Publication Number Publication Date
NO996234D0 NO996234D0 (no) 1999-12-16
NO996234L true NO996234L (no) 2000-03-10

Family

ID=25399881

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996234A NO996234L (no) 1997-07-14 1999-12-16 Sprayformuleringer av antihyperalgesiske opiater og fremgangsmåte for behandling av topiske hyperalgesiske forhold og kløe med disse

Country Status (9)

Country Link
US (1) US5798093A (no)
EP (1) EP1011647A4 (no)
JP (1) JP2001510153A (no)
KR (1) KR20010021851A (no)
AU (1) AU724727B2 (no)
BR (1) BR9810711A (no)
CA (1) CA2288132A1 (no)
NO (1) NO996234L (no)
WO (1) WO1999003457A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6353004B1 (en) * 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
US6541517B1 (en) 1999-09-03 2003-04-01 Donald M. Murphy Treatment of skin disorders
US6117904A (en) * 1999-09-03 2000-09-12 Murphy; Donald M. Treatment of pruritus
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
TWI250023B (en) * 2001-10-22 2006-03-01 Santen Pharmaceutical Co Ltd Pharmaceutical composition for itch treating agent
WO2004099194A1 (ja) * 2003-05-08 2004-11-18 Kyorin Pharmaceutical Co. Ltd. 掻痒治療薬として有用な４－（２－フロイル）アミノピペリジン類
EP2132175B1 (en) * 2006-12-28 2012-05-02 Institut Univ. de Ciència i Tecnologia, S.A. Process for the preparation of loperamide
FR2915097B1 (fr) * 2007-04-18 2012-09-28 Fabre Pierre Dermo Cosmetique Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617282A1 (de) * 1965-11-30 1975-02-06 Astra Pharma Prod Vorrichtung zur lokalanaesthetisierung durch oertliche aufbringung und verfahren zur herstellung dieser vorrichtung
US3624224A (en) * 1969-12-22 1971-11-30 Schering Corp Novel first aid products
US3884916A (en) * 1971-03-30 1975-05-20 Janssen Pharmaceutica Nv 2,2-Diaryl-4-(4-aryl-4-hydroxy-piperidino)-butyramides
US3714159A (en) * 1971-03-30 1973-01-30 Janssen Pharmaceutica Nv 2,2-diaryl-4-(4'-aryl-4'-hydroxy-piper-idino)-butyramides
US5035883A (en) * 1988-09-02 1991-07-30 Albert L. Jacobs Composition and method for treating human disorders susceptible to antimicrobial treatment
US5116847A (en) * 1991-01-25 1992-05-26 The Procter & Gamble Company Use of loperamide and related compounds for treatment of respiratory disease symptoms
JPH10500669A (ja) * 1994-04-12 1998-01-20 アルザ・コーポレーション サイトカイン阻害薬に関するスクリーニング法
US5516808A (en) * 1994-10-27 1996-05-14 Sawaya; Assad S. Topical cellulose pharmaceutical formulation
US5576346A (en) * 1995-04-03 1996-11-19 Ascent Pharmaceuticals, Inc. Process for treating uremic pruritus
US5667773A (en) * 1996-03-12 1997-09-16 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith

Also Published As

Publication number Publication date
EP1011647A1 (en) 2000-06-28
BR9810711A (pt) 2000-08-08
WO1999003457A1 (en) 1999-01-28
KR20010021851A (ko) 2001-03-15
JP2001510153A (ja) 2001-07-31
AU8074898A (en) 1999-02-10
EP1011647A4 (en) 2001-05-16
NO996234D0 (no) 1999-12-16
CA2288132A1 (en) 1999-01-28
AU724727B2 (en) 2000-09-28
US5798093A (en) 1998-08-25

Similar Documents

Publication Publication Date Title
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
NO996352L (no) Kappaagonistforbindelser, farmasøytiske formuleringer og metode for forhindring og behandling av kløe med disse
NO996234L (no) Sprayformuleringer av antihyperalgesiske opiater og fremgangsmåte for behandling av topiske hyperalgesiske forhold og kløe med disse
ID30322A (id) HETEROSIKLIK YANG MENGANDUNG INHIBITOR BIFENIL aP2 DAN METODANYA
DE69621830T2 (de) Alpha-substituierte arylsulphonamidohydroxamsaüre als tnf-alpha und matrix-metalloproteinase-inhibitoren
DE69838374D1 (de) Prozessor und Verfahren zum Verringern von dessen Energieverbrauch
DE69913530D1 (de) Benzothiepinen mit wirkung als inhibitoren des ileumgallensäuretransports und der taurocholate-aufnahme
NO975759D0 (no) Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel
DK0934301T3 (da) Aminothiophencarboxylsyreamider og anvendelse deraf som phosphodiesteraseinhibitorer
NO20004098L (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
DE69836008D1 (de) Zusammensetzung und behandlungsmittel
EP1009404A4 (en) PROCESS FOR TREATING INFLAMMATION OR INFLAMMATORY DISEASES USING POLY-ADP RIBOSE POLYMERASE INHIBITORS
NO972125D0 (no) Hemmoroideblandinger og fremgangsmåte for anvendelse
NO20015274D0 (no) ACE-2 inhiberende forbindelser og fremgangsmåter for anvendelse derav
DE69802229D1 (de) Kesselstein verhinderndes Mittel und Verfahren zum Verwenden desselben
ZA988017B (en) Parp inhibitors pharmaceutical compositions comprising same and methods of using same
DE69511240D1 (de) Derivate des hydroxamsäure als metalloproteinaseinhibitoren
NO996351L (no) Filmdannende komposisjoner av antihyperalgesiske opiater og metode for behandling av hyperalgesiske og kløetilstander med disse
NO993066D0 (no) Ny behandling for leddinflammasjon
PL339836A1 (en) Phtalazine compounds and therapeutic agents suitable to treat erection disorders
ATE267196T1 (de) Sulfonylbenzolverbindungen als analgetische und entzündungshemmende mittel
ITRM950557A0 (it) Metodo per determinare l'attivita' terapeutica di composti inibitori di metalloproteinasi, nuovi composti inibitori, e loro impiego terapeutico
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
PT826679E (pt) Compostos de naftilo intermediarios composicoes e metodos de utilizacao
NO20020326L (no) Sammensetning og anvendelse av en inhibitor av PPAR-delta-aktivitet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application